Mejorar el acceso de los pacientes a los ensayos clínicos sobre el cáncer en todo el país.

Diagnosed with AML, Laura Beth West faced a series of daunting challenges along her journey to be cancer free. After intense treatment with chemo, she went into remission, but discovered that some cancer remnants remained and kept growing, so she went to MD Anderson for additional help. That’s when they offered her the option to participate in a clinical trial.

At Lazarex Cancer Foundation we help identify FDA cancer clinical trial options, and reimburse out of pocket travel expenses for travel to cancer clinical trial treatments. We make lifesaving connections that give hope to patients now, and opportunity for new treatments in the future.

The state of diversity in cancer clinical trials today reflects persistent inequities, with minority racial and ethnic groups being underrepresented. Efforts to improve diversity have faced challenges, including low participation rates among African American and Hispanic American individuals. It is crucial for industry sponsors to prioritize diversity and for Congress to extend mandates to all cancer clinical trials to address this issue effectively.